September 28, 2016 6:18 AM ET

Diversified Consumer Services

Company Overview of The University of Chicago

Company Overview

The University of Chicago is an educational institution that offers undergraduate, graduate, and professional programs in the fields of biology, humanity, law, social service, and physical science. The schools of the university include Divinity School, Booth School of Business, Graham School of General Studies, Harris Graduate School of Public Policy Studies, Law School, Pritzker School of Medicine, and School of Social Service Administration. The University of Chicago was founded in 1890 and is based in Chicago, Illinois. It has endowment assets of $3963.4 millions.

5801 South Ellis Avenue

Room 200

Chicago, IL 60637-5418

United States

Founded in 1890

Phone:

773-702-1234

Fax:

773-702-8324

Key Executives for The University of Chicago

President and Trustee
Founder and Life Trustee
Age: 100
Vice President for Administration and Chief Financial Officer
Professor of Accounting
Age: 63
Adjunct Professor of Finance
Age: 48
Compensation as of Fiscal Year 2016.

The University of Chicago Key Developments

The University of Chicago Department of Pediatrics Presents at Sachs Associates 2nd Annual Immune-Oncology BD&L and Investment Forum, Jun-03-2016 05:00 PM

The University of Chicago Department of Pediatrics Presents at Sachs Associates 2nd Annual Immune-Oncology BD&L and Investment Forum, Jun-03-2016 05:00 PM. Venue: Hyatt Chicago Magnificent Mile, 633 North Saint Clair Street, Chicago, IL 60611, United States. Speakers: Rena Conti, Assistant Professor Hematology/Oncology.

twoXAR, Inc. Enters Research Collaboration with Department of Medicine at University of Chicago

twoXAR Inc. announced a collaboration with the Department of Medicine at the University of Chicago focused on the identification and investigation of potential new medicines for treating atherosclerosis. As part of this collaboration, twoXAR will use its disease-to-candidate prediction software to integrate and analyze diverse biomedical data sets to predict efficacious drug candidates for in vivo testing. Researchers at the University of Chicago will test the effectiveness of predicted drug candidates in promoting vascular endothelial health and in preventing atherosclerosis. Cultured endothelial cells treated with the predicted molecules will be stimulated by tumor necrosis factor alpha (TNFa) in vitro followed by in vivo testing in animal models of atherosclerosis. twoXAR will provide scientific expertise to assist the Department of Medicine at the University of Chicago in the selection and delivery of candidates for pre-clinical study.

AbbVie and University of Chicago Collaborate to Advance Cancer Research

The University of Chicago and AbbVie entered into a five-year collaboration agreement designed to improve the pace of discovery and advance medical research in oncology at both organizations. The joint strategic research agreement between AbbVie and the University of Chicago is designed to encourage and strengthen collaboration among researchers. Initially, both organizations will work together to advance research in several areas of oncology, which could include, among others, breast, lung, prostate, colorectal and hematological cancer. Research projects are chosen by a joint steering committee, comprised of representatives from each organization. AbbVie also gains an option for an exclusive license to certain University of Chicago discoveries made under the agreement. As part of the agreement, AbbVie will provide funding for the collaboration that may be used for purposes including preclinical research, clinical trials and possible future programs at the University resulting from this partnership. The overall collaborative efforts will provide University of Chicago physicians and scientists with the opportunity to participate in AbbVie-sponsored clinical trials, access to new therapies developed by AbbVie for use in preclinical research funded under the collaboration, as well as opportunities to work closely with AbbVie's research and development teams to promote scientific knowledge exchange. As part of the collaborative agreement, researchers from the University of Chicago and AbbVie will participate in an annual symposium that brings together scientists from both institutions to discuss research and evaluate potential new projects. Collaborative efforts also provide AbbVie researchers with access to data commons technology developed by the Center for Data Intensive Science at the University of Chicago and the core technical team that is developing the technology.

Similar Private Companies By Industry

Company Name Region
1-800-Dryclean, LLC United States
1-800-PHONESEX United States
125 Max Drycleaning Center LLC United States
180 Skills LLC United States
19Pencils, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact The University of Chicago, please visit www.uchicago.edu. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.